# Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit

> **NCT03183544** · PHASE1 · COMPLETED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 3 (actual)

## Conditions studied

- Prostatic Neoplasm

## Interventions

- **COMBINATION_PRODUCT:** Gallium-68 PSMA-11 prepared using PSMA-11 Sterile Cold Kit

## Key facts

- **NCT ID:** NCT03183544
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-24
- **Primary completion:** 2020-02-24
- **Final completion:** 2020-02-24
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2020-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183544, "Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03183544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*